These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6865972)

  • 21. [A case of rare side effects of certain antidepressive drugs].
    Haenel T; Stöckli HR; Truog P
    Nervenarzt; 1995 Jan; 66(1):70-2. PubMed ID: 7885518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet monoamine oxidase activity and human sleep.
    Mendelson WB; Buchsbaum MS; Murphy DL; Wyatt RJ; Gillin JC
    Commun Psychopharmacol; 1978; 2(6):539-44. PubMed ID: 218771
    [No Abstract]   [Full Text] [Related]  

  • 23. [The Eppendorf Mood and Motivation Scale as assessment procedure in the clinical evaluation of an antidepressive agent].
    Binz U; Wendt G
    Fortschr Med; 1982 Dec; 100(45):2111-7. PubMed ID: 6757074
    [No Abstract]   [Full Text] [Related]  

  • 24. [Combined chlorimipramine and maprotiline therapy in therapy-resistant depressions].
    Soucek K
    Act Nerv Super (Praha); 1982 May; 24(2):88-9. PubMed ID: 7102229
    [No Abstract]   [Full Text] [Related]  

  • 25. Severe depression treatment: experience using maprotiline (Ludiomil) in combination with clomipramine (Anafranil).
    Ovuga E
    East Afr Med J; 1985 Feb; 62(2):79-81. PubMed ID: 4042927
    [No Abstract]   [Full Text] [Related]  

  • 26. Prediction of response to nortriptyline and phenelzine by platelet MAO activity.
    Georgotas A; McCue RE; Friedman E; Cooper T
    Am J Psychiatry; 1987 Mar; 144(3):338-40. PubMed ID: 3826434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of carbamazepine combined with an ineffective antidepressant. Apropos of 4 cases].
    Navarre C; Maurin C; Colonna L
    Encephale; 1994; 20(1):79-80. PubMed ID: 8174514
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical experience with maprotilin and maprotilin/clomipramine infusions in resistant depression.
    Zapletálek M; Zbytovský J; Kudrnová K
    Act Nerv Super (Praha); 1982 May; 24(2):73-6. PubMed ID: 7102227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of total sleep deprivation and subsequent treatment with clomipramine on depressive symptoms and sleep electroencephalography in patients with a major depressive disorder.
    Riemann D; Berger M
    Acta Psychiatr Scand; 1990 Jan; 81(1):24-31. PubMed ID: 2330825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet monoamine oxidase activity in affective disorder.
    Fieve RR; Kumbaraci T; Kassir S; Dunner DL; Cote L
    Biol Psychiatry; 1980 Jun; 15(3):473-8. PubMed ID: 7378520
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapeutic sleep deprivation and antidepressant medication in patients with major depression.
    Kasper S; Kick H; Voll G; Vieira A
    Eur Neuropsychopharmacol; 1991 May; 1(2):107-11. PubMed ID: 1821699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The antidepressive maprotiline: symposium at Hradec Kralove 26 November 1980].
    Act Nerv Super (Praha); 1982 May; 24(2):39-118. PubMed ID: 7102224
    [No Abstract]   [Full Text] [Related]  

  • 33. Predicting therapeutic results with levoprotiline and maprotiline in major depression: the role of the outcome criteria.
    Filip V; Höschl C; Karen P; Seifertová D; Bornová L; Prasková H; Prasko J
    Br J Psychiatry Suppl; 1993 Sep; (21):35-8. PubMed ID: 8217066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of two endogenicity measures.
    D'haenen H; De Weert D; Feyaerts M
    Psychopathology; 1990; 23(3):157-60. PubMed ID: 2277823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Critical view of biochemical factors in depressive syndromes and the prescription of antidepressants].
    Loo H; Zarifian E
    Ann Med Psychol (Paris); 1982 Feb; 140(2):240-51. PubMed ID: 6180668
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chronotherapeutic approaches in depressive disorders].
    Berger M; Hohagen F; König A; Vollmann J; Lohner H; Faller C; Edali N; Riemann D
    Wien Med Wochenschr; 1995; 145(17-18):418-22. PubMed ID: 8588356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous modulation of platelet monoamine oxidase activity.
    Becker RE
    Prog Clin Biol Res; 1985; 192():355-8. PubMed ID: 4080715
    [No Abstract]   [Full Text] [Related]  

  • 38. Alterations of blood platelet MAO-B activity and LSD-binding in humans after sleep deprivation and recovery sleep.
    Schreiber W; Opper C; Dickhaus B; Heiser P; Wesemann W; Krieg JC
    J Psychiatr Res; 1997; 31(3):323-31. PubMed ID: 9306290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical evaluation of the antidepressive action of sulfoadenosyl-L-methionine compared with that of chlorimipramine].
    Giner Ubago J; González Infante JM; Blanco Picabia A
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984; 12(1):73-80. PubMed ID: 6372376
    [No Abstract]   [Full Text] [Related]  

  • 40. [Subgroup of bipolar primary affective illness with increased value of Michaelis' constant of monoamine oxidase of blood platelets].
    Landowski J; Lysiak W; Angielski S
    Psychiatr Pol; 1978; 12(4):449-56. PubMed ID: 724835
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.